Cargando…
Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor
Sepsis is a serious condition that can lead to long-term organ damage and death. At the molecular level, the hallmark of sepsis is the elevated expression of a multitude of potent cytokines, i.e. a cytokine storm. For sepsis involving gram-negative bacteria, macrophages recognize lipopolysaccharide...
Autores principales: | Noori, Mahboubeh S., Courreges, Maria C., Bergmeier, Stephen C., McCall, Kelly D., Goetz, Douglas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334664/ https://www.ncbi.nlm.nih.gov/pubmed/32634441 http://dx.doi.org/10.1016/j.ejphar.2020.173340 |
Ejemplares similares
-
Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19
por: Ghazanfari, Davoud, et al.
Publicado: (2022) -
Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD
por: McCall, Kelly D, et al.
Publicado: (2023) -
Glycogen synthase kinase-3β inhibitor reduces LPS-induced acute lung injury in mice
por: Ding, Qi, et al.
Publicado: (2017) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization
por: Courreges, Maria C., et al.
Publicado: (2012)